The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure …

M Van Bilsen, HC Patel, J Bauersachs… - European journal of …, 2017 - Wiley Online Library
Despite improvements in medical therapy and device‐based treatment, heart failure (HF)
continues to impose enormous burdens on patients and health care systems worldwide …

Myocardial hypertrophy and its role in heart failure with preserved ejection fraction

FR Heinzel, F Hohendanner, G Jin… - Journal of applied …, 2015 - journals.physiology.org
Left ventricular hypertrophy (LVH) is the most common myocardial structural abnormality
associated with heart failure with preserved ejection fraction (HFpEF). LVH is driven by …

Renal Denervation and Symplicity HTN-3: “Dubium Sapientiae Initium” (Doubt Is the Beginning of Wisdom)

V Papademetriou, C Tsioufis, M Doumas - Circulation research, 2014 - Am Heart Assoc
212 Circulation Research July 7, 2014 and others19, 20 confirmed and re-enforced these
observations. Furthermore, Osborn et al21 demonstrated that low-frequency stimulation of …

Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance …

F Mahfoud, D Urban, D Teller, D Linz… - European heart …, 2014 - academic.oup.com
Aims Sympathetic stimulation induces left ventricular hypertrophy and is associated with
increased cardiovascular risk. Catheter-based renal denervation (RDN) has been shown to …

Renal sympathetic denervation in patients with heart failure with preserved ejection fraction

KP Kresoja, KP Rommel, K Fengler… - Circulation: Heart …, 2021 - Am Heart Assoc
Background: Arterial hypertension is the most common comorbidity in patients with heart
failure with preserved ejection fraction (HFpEF) and mediates adverse hemodynamics …

Cardiorenal syndrome and heart failure—challenges and opportunities

H Yogasundaram, MC Chappell, B Braam… - Canadian Journal of …, 2019 - Elsevier
Cardiorenal syndromes (CRS) describe concomitant bidirectional dysfunction of the heart
and kidneys in which 1 organ initiates, perpetuates, and/or accelerates decline of the other …

Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension

L Donazzan, F Mahfoud, S Ewen, C Ukena… - Clinical Research in …, 2016 - Springer
Objectives To investigate, whether renal denervation (RDN) has a direct effect on cardiac
sympathetic activity and innervation density. Background RDN demonstrated its efficacy not …

Comparison of long‐term outcomes for responders versus non‐responders following renal denervation in resistant hypertension

K Fengler, P Reimann, KP Rommel… - Journal of the …, 2021 - Am Heart Assoc
Background Recent trial results support the efficacy of renal sympathetic denervation in
lowering blood pressure (BP). While BP reduction in general is associated with a clinically …

Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?

M Böhm, D Linz, C Ukena, M Esler… - Circulation research, 2014 - Am Heart Assoc
Hypertension imposes a major burden of morbidity and mortality and is associated with
sympathetic nervous system overactivity. Renal sympathetic denervation has been shown to …

Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly

H Toba, ML Lindsey - Pharmacology & therapeutics, 2019 - Elsevier
Whereas hypertension, diabetes, and dyslipidemia are age-related risk factors for
cardiovascular disease (CVD) and chronic kidney disease (CKD), aging alone is an …